Luke Halpern, Assistant Editor from Pharmacy Times - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Luke Halpern, Assistant Editor Pharmacy Times		Lumateperone Demonstrates Positive Efficacy for Schizophrenia Relapse Prevention - 3 days ago FDA Approves Obecabtagene Autoleucel for Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia - 3 days ago Semaglutide Improves Liver Fibrosis in Patients with Metabolic Dysfunction-Associated Steatohepatitis - 3 days ago Providers Prefer Increased Pneumonia, IPD Coverage and Lower Age Recommendation For Pneumococcal Vaccines - 5 days ago Moderna Bivalent COVID-19 Vaccine More Effective at Preventing Hospitalization in High-Risk Patients Compared With Pfizer-BioNTech Vaccine - 6 days ago FDA Grants Orphan Drug Designation to Ifetroban for Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy - 6 days ago Expert: Independent Pharmacies Express Unique Value to Providers, Community - 7 days ago Risk of Developing Eosinophilic Esophagitis Is Higher in Pediatric Patients With Atopic Conditions - 7 days ago Implementation of Supply-Related Restrictive Measures Reduces IVIG Use - 7 days ago Cigarette Smoke Hinders Innate Immune Response to Pneumococcal infection - 8 days ago New Guselkumab Data Indicate Robust Effectiveness in Crohn Disease, Plaque Psoriasis - 11 days ago In Utero Exposure to Maternal COVID-19 Has No Association With Abnormal Neurodevelopment - 13 days ago IVIG Prescriptions Guideline-Appropriate in Majority of French Adults With Severe Immune Thrombocytopenia - 14 days ago Early Treatment With Sebetralstat Correlates With Shorter Duration of Hereditary Angioedema Attacks - 15 days ago Patients With Generalized Myasthenia Gravis Demonstrate Rapid Response Following Ravulizumab Treatment - 20 days ago FDA Approves Companion Diagnostic To Identify Patients With Grade 2 IDH-Mutant Glioma Eligible for Vorasidenib - 25 days ago American Pharmacists Month: Frank Kessler Reflects on Decades of Work in Community Pharmacy - 25 days ago Repeat IVIG Dosing Common in Guillain-Barré Syndrome, Suggesting Harm in Non-Responders - 27 days ago Nivolumab-Chemotherapy Combination Lengthens Survival, Causes Manageable Adverse Effects in Stage III or IV Classic Hodgkin Lymphoma - 28 days ago Risk of Type 2 Diabetes In Children Increases Following SARS-CoV-2 Infection - 29 days ago Loncastuximab Tesirine Demonstrates Promise in Managing Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-Cell Lymphoma - 30 days ago High-Dose IVIG With Glucocorticoids Shown to Benefit Patients With Kawasaki Disease at High Risk For IVIG Resistance - about 1 month ago New CDC Data Show Decrease in Vaccine Coverage Among Kindergarteners For 2023-2024 School Year - about 1 month ago Acalabrutinib-Rituximab Combination Effective in Relapsed/Refractory, Treatment-Naive Follicular Lymphoma - about 1 month ago FDA Grants Orphan Drug Designation to LQT-1213 to Treat Patients With Long QT Syndrome - about 1 month ago Cologuard Plus Receives FDA Approval For Non-Invasive Colorectal Cancer Screening - about 1 month ago Hospitalized COVID-19 Patients Face Worsened Long-Term Cognitive Function - about 1 month ago Lower Dose of IVIG Remains Effective in Treating Pediatric Immune Thrombocytopenia Compared With Higher Dose - about 1 month ago American Pharmacists Month: Alan Corley Discusses Importance of Pharmacy to Patients - about 1 month ago Experts Develop Multimodal Approach for Treating Long COVID, Other Post-Acute Infectious Syndromes - 2 months ago Atezolizumab and Hyaluronidase-tqjs Subcutaneous Formulation Receives FDA Approval to Treat Multiple Forms of Cancer - 2 months ago HIV Infections Significantly Reduced With Twice-Yearly Lenacapavir in Cisgender Men, Gender-Diverse Participants - 2 months ago Innovative DLL3 Targeting Mechanisms Will Lead to New Approaches in SCLC, LCNEC - 2 months ago Cutting-Edge Targeted, Cytotoxic, and Immunologic Therapies Form Next Generation of mNSCLC Treatments - 2 months ago Tocilizumab Effective in Patients With Inadequate Response to Intravenous Immunoglobulin for MOGAD - 2 months ago IVIG Associated With Shorter Hospital, ICU Length of Stay in Immunocompromised Patients With Respiratory Infections - 2 months ago Positive New Data Highlighting Tarlatamab-dlle Safety, Anticancer Activity Presented at WCLC 2024 - 2 months ago IVIG Shows Promise as Therapy in Patients With Recurrent Implantation Failure - 2 months ago FDA Approves Diagnostics for Olaparib, Abiraterone Combination Therapy in Patients With BRCA-Mutated mCRPC - 2 months ago Tolebrutinib Shows Reduction in Disability Accumulation in Non-Relapsing Secondary Progressive Multiple Sclerosis - 2 months ago Insurance Status, Survival Outcomes Linked in Patients With Diffuse Large B-Cell Lymphoma - 2 months ago FDA Authorizes New Drug Application For Trial to Evaluate Treatment for Long COVID - 2 months ago Effective Health Care Delivery Models, Partnerships Can Ease Burden of Diabetes - 3 months ago Cytomegalovirus Infection in Patients with Lymphoma Treated With Bendamustine Are Underdiagnosed, Require Awareness - 3 months ago Updated COVID-19 Vaccines Approved by FDA to Defend Against Circulating Variants - 3 months ago Insight: Sustainable Care Models Must Expand Role of Pharmacist, Reach Patients Where They Are - 3 months ago FDA Accepts Biologics License Application For Nivolumab Plus Ipilimumab to Treat Hepatocellular Carcinoma - 3 months ago Expert: Alignment Across Pharmacy Profession Can Lead to Effective Policy, Optimized Treatment - 3 months ago NACDS President: Technological Innovation, Policy Initiatives Key Focuses for Future - 3 months ago Expert: Emphasis on Diabetes Research Can Close Gaps in Marginalized Communities - 3 months ago